DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,361,890 | +10.0% | 428,691 | +6.4% | 0.17% | +11.5% |
| Q2 2023 | $96,719,974 | +10.4% | 402,978 | +16.0% | 0.16% | +5.4% |
| Q1 2023 | $87,575,151 | +1.7% | 347,443 | +7.1% | 0.15% | -2.6% |
| Q4 2022 | $86,124,616 | +64.9% | 324,476 | +60.5% | 0.15% | +40.7% |
| Q3 2022 | $52,228,000 | -0.2% | 202,187 | -2.1% | 0.11% | +6.9% |
| Q2 2022 | $52,356,000 | -14.1% | 206,497 | -0.6% | 0.10% | 0.0% |
| Q1 2022 | $60,915,000 | -12.0% | 207,652 | -1.3% | 0.10% | -7.3% |
| Q4 2021 | $69,216,000 | +6.9% | 210,378 | -1.1% | 0.11% | -10.7% |
| Q3 2021 | $64,746,000 | +12.3% | 212,660 | -1.0% | 0.12% | +13.0% |
| Q2 2021 | $57,661,000 | +16.0% | 214,859 | -2.7% | 0.11% | +6.9% |
| Q1 2021 | $49,716,000 | +0.0% | 220,885 | -1.3% | 0.10% | -5.6% |
| Q4 2020 | $49,696,000 | +0.1% | 223,723 | -2.9% | 0.11% | -11.6% |
| Q3 2020 | $49,626,000 | +20.0% | 230,471 | -1.4% | 0.12% | +12.0% |
| Q2 2020 | $41,345,000 | +27.5% | 233,812 | -0.2% | 0.11% | +6.9% |
| Q1 2020 | $32,432,000 | -11.0% | 234,321 | -1.3% | 0.10% | +8.6% |
| Q4 2019 | $36,434,000 | +5.4% | 237,378 | -0.8% | 0.09% | -1.1% |
| Q3 2019 | $34,558,000 | -0.3% | 239,286 | -1.4% | 0.09% | -3.1% |
| Q2 2019 | $34,674,000 | +7.4% | 242,609 | -0.8% | 0.10% | +4.3% |
| Q1 2019 | $32,298,000 | +25.8% | 244,651 | -1.7% | 0.09% | +12.0% |
| Q4 2018 | $25,672,000 | -1.9% | 248,955 | +3.4% | 0.08% | +9.2% |
| Q3 2018 | $26,157,000 | +7.2% | 240,721 | -2.7% | 0.08% | +1.3% |
| Q2 2018 | $24,402,000 | +0.3% | 247,283 | -0.4% | 0.08% | 0.0% |
| Q1 2018 | $24,320,000 | +4.2% | 248,384 | -1.2% | 0.08% | +5.6% |
| Q4 2017 | $23,334,000 | +8.7% | 251,389 | +0.4% | 0.07% | +2.9% |
| Q3 2017 | $21,468,000 | +5.2% | 250,266 | +3.5% | 0.07% | +1.5% |
| Q2 2017 | $20,406,000 | -3.2% | 241,799 | -1.9% | 0.07% | -5.6% |
| Q1 2017 | $21,075,000 | +9.9% | 246,409 | +0.1% | 0.07% | +4.3% |
| Q4 2016 | $19,169,000 | +3.6% | 246,268 | +4.3% | 0.07% | 0.0% |
| Q3 2016 | $18,509,000 | -21.6% | 236,116 | +1.0% | 0.07% | -23.3% |
| Q2 2016 | $23,620,000 | +12.7% | 233,867 | +5.8% | 0.09% | +9.8% |
| Q1 2016 | $20,959,000 | +7.9% | 220,948 | +5.6% | 0.08% | +5.1% |
| Q4 2015 | $19,431,000 | +12.2% | 209,216 | +2.9% | 0.08% | +6.8% |
| Q3 2015 | $17,324,000 | -0.5% | 203,310 | -0.1% | 0.07% | +9.0% |
| Q2 2015 | $17,412,000 | -2.2% | 203,437 | -3.0% | 0.07% | -1.5% |
| Q1 2015 | $17,801,000 | -3.3% | 209,677 | -2.4% | 0.07% | -4.2% |
| Q4 2014 | $18,411,000 | +10.7% | 214,799 | -1.9% | 0.07% | +6.0% |
| Q3 2014 | $16,638,000 | -14.7% | 218,978 | -11.6% | 0.07% | -14.1% |
| Q2 2014 | $19,502,000 | +3.9% | 247,708 | -1.0% | 0.08% | +1.3% |
| Q1 2014 | $18,769,000 | -5.4% | 250,257 | -2.7% | 0.08% | -3.8% |
| Q4 2013 | $19,848,000 | +12.4% | 257,099 | +0.9% | 0.08% | +2.6% |
| Q3 2013 | $17,658,000 | +5.6% | 254,740 | -3.6% | 0.08% | +2.6% |
| Q2 2013 | $16,727,000 | – | 264,249 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |